BioAge Labs Inc. – Filings and Transcripts

NASDAQ: BIOA
Share price (5/22/26): $16.61
Market cap (5/22/26): $738 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Automatic shelf registration

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Shelf registration – amended

Ownership Filter

Khosla Ventures VI, L.P.

Cormorant Asset Management, LP

Goldstein Dov a MD

News Filter

Reports First Quarter 2026 Financial Results and Provides Business Updates

Reports Full Year 2025 Financial Results and Provides Business Updates From the Fourth Quarter of 2025

Announces Pricing of Upsized $115.0 Million Public Offering

Announces Indication Expansion for Oral NLRP3 Inhibitor BGE-102, With Plans to Initiate Phase 1b/2a Proof-Of-Concept Clinical Trial in Patients With Diabetic Macular Edema in Mid-2026

Announces Additional Positive Interim Phase 1 Data for BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor, Demonstrating Potential for Best-In-Class hsCRP Reduction in Participants With Elevated Cardiovascular Risk

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

SEC STAFF LETTER

Notice of effectiveness